Investor’s Toolkit: Key Ratios for Assessing Olema Pharmaceuticals Inc (OLMA)’s Performance

Kevin Freeman

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

Olema Pharmaceuticals Inc (NASDAQ: OLMA) closed the day trading at $28.18 up 0.90% from the previous closing price of $27.93. In other words, the price has increased by $0.90 from its previous closing price. On the day, 2.35 million shares were traded. OLMA stock price reached its highest trading level at $28.9799 during the session, while it also had its lowest trading level at $26.402.

Ratios:

For a better understanding of OLMA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.03 and its Current Ratio is at 8.03. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In the most recent recommendation for this company, Guggenheim on October 08, 2025, initiated with a Buy rating and assigned the stock a target price of $20.

On August 12, 2025, Citigroup reiterated its Buy rating and also lowered its target price recommendation from $20 to $21.

On April 02, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $24.Goldman initiated its Buy rating on April 02, 2024, with a $24 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 22 ’25 when Harmon Cyrus bought 2,881 shares for $28.53 per share.

Zojwalla Naseem bought 100,000 shares of OLMA for $2,804,039 on Dec 22 ’25. On Dec 19 ’25, another insider, Myles David C., who serves as the Officer of the company, bought 51,000 shares for $30.46 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 2258906624 and an Enterprise Value of 1610354688.

Stock Price History:

The Beta on a monthly basis for OLMA is 1.92, which has changed by 3.419304 over the last 52 weeks, in comparison to a change of 0.13153219 over the same period for the S&P500. Over the past 52 weeks, OLMA has reached a high of $36.26, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is 57.43%, while the 200-Day Moving Average is calculated to be 229.54%.

Shares Statistics:

Over the past 3-months, OLMA traded about 3.74M shares per day on average, while over the past 10 days, OLMA traded about 3674210 shares per day. A total of 68.65M shares are outstanding, with a floating share count of 65.65M. Insiders hold about 16.54% of the company’s shares, while institutions hold 75.10% stake in the company. Shares short for OLMA as of 1764288000 were 10810748 with a Short Ratio of 2.89, compared to 1761868800 on 8366665. Therefore, it implies a Short% of Shares Outstanding of 10810748 and a Short% of Float of 14.63.

Earnings Estimates

Current recommendations for the stock of the company come from 7.0 analysts. The consensus estimate for the next quarter is -$0.54, with high estimates of -$0.51 and low estimates of -$0.57.

Analysts are recommending an EPS of between -$1.83 and -$2.22 for the fiscal current year, implying an average EPS of -$1.93. EPS for the following year is -$2.33, with 6.0 analysts recommending between -$1.86 and -$2.66.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.